Today, we commemorate the International Day of Women and Girls in Science. While global statistics continue to highlight unequal representation in technical fields, here in Hradec Králové we are writing a very different story — a story in which expertise, molecular biology, and innovation bear women’s names in 89% of cases.
This important day, observed on February 11, was proclaimed by the United Nations General Assembly in 2015. Its objective is to ensure equal access for women and girls to education and scientific careers and to eliminate barriers in STEM fields (Science, Technology, Engineering, and Mathematics).
When examining the data, it is evident that the potential of women in Czech science often remains underutilized.
At GENERI BIOTECH, we move against national and global statistical trends. Currently, 89% of our employees are women. This is not the result of quotas, but rather the natural evolution of a modern biotechnology company that prioritizes talent and precision.
Our female colleagues play a key role throughout the entire lifecycle of our products:
Applied Research and Development: Development of diagnostic kits for human medicine.
Molecular Genetics: Comprehensive analyses and laboratory testing.
Quality Control: Rigorous oversight of standards that are critical in biotechnology.
Management and Business Development: Bridging scientific knowledge with market needs.
“Science at our company is not about gender, but about the ability to see connections where others see only data. The strong representation of women within our team brings exceptional precision and an innovative perspective to our work,” says the company’s leadership.
Although men represent the remaining 11%, together we form one strong and balanced team. We believe that success in molecular biology and biotechnology depends on an environment that supports talent development regardless of prejudice.
Today is an opportunity for us to thank all our female colleagues. Thanks to you, GENERI BIOTECH ranks among the leaders of the Czech and European markets. Thank you for helping us push the boundaries of modern science.
Leona Hofmeisterová
gb HEMO FII (G20210A) Kit slouží k detekci mutace G20210A ve srážecím faktoru II v lidské genomové DNA. Princip detekce je založen na real-time polymerázové řetězové reakci (qPCR) s využitím fluorescenčně značených sond (alelická diskriminace).
gb ONCO BRAF (V600) Kit slouží k detekci a kvantifikaci somatické mutace V600E, E2, D, D2, K, R a M genu BRAF v lidské genomové DNA. Vyšetření je založeno na metodice real-time PCR s využitím fluorescenčně značených sond a alelově specifických primerů. Souprava obsahuje všechny potřebné komponenty pro provedení analýzy.
gb PCR Špičky s filtrem gb PCR Špičky s filtrem jsou vybaveny integrovaným filtrem, který slouží jako bariéra proti aerosolům a účinně zabraňuje vnitřní kontaminaci pipety. Jsou ideální pro přesnou a spolehlivou rutinní manipulaci s kapalinami a pro PCR aplikace.
V posledních několika dnech se v GB roztrhl pytel s dotazy ohledně testování SRY. Buď na dostupnost kitů pro detekci genu SRY nebo na možnost provést celé vyšetření. Zjistili jsme, že mezinárodní federace atletiky od 1. září 2025 zavádí jednorázový test na přítomnost genu SRY, který indikuje přítomnost Y chromozomu. Tento test je podmínkou pro zařazení do ženské kategorie
Your request has been sent.
Thank you for your interest in our testing services. We will reply to your e-mail address as soon as possible.
Thank you for your inquiry
Thank you for your inquiry
Your registration has been sent.
Thank you for your inquiry
ENG 
CZE